|
Q4 2024
|
67 |
352,567 |
ADMA, VERA, SRPT, KMPH
|
13F-HR
|
2/13/2025 |
000142050625000357 |
|
Q3 2024
|
79 |
339,708 |
VERA, ADMA, SRPT, EW
|
13F-HR
|
11/14/2024 |
000142050624002530 |
|
Q2 2024
|
68 |
245,120 |
VERA, ADMA, XENE, ITCI
|
13F-HR
|
8/14/2024 |
000142050624001576 |
|
Q1 2024
|
72 |
252,672 |
VERA, XENE, VIKING THERAPEUTICS INC puts, ADVISORSHARES TR calls
|
13F-HR
|
5/15/2024 |
000142050624000943 |
|
Q4 2023
|
66 |
147,309 |
XENE, ALIM, AXSM, BOXX
|
13F-HR
|
2/14/2024 |
000142050624000382 |
|
Q3 2023
|
72 |
191,744 |
CBAY, IMMUNOVANT INC puts, IMGN, ATXS
|
13F-HR
|
11/14/2023 |
000142050623002134 |
|
Q2 2023
|
68 |
132,122 |
KDNY, ATXS, IMGN, ADMA
|
13F-HR
|
8/14/2023 |
000142050623001711 |
|
Q1 2023
|
91 |
180,149 |
ATXS, NOVOCURE LTD calls, ADMA, BLU.TO
|
13F-HR
|
5/15/2023 |
000142050623001113 |
|
Q4 2022
|
94 |
196,777 |
ATXS, ADMA, KDNY, BLU.TO
|
13F-HR
|
2/14/2023 |
000142050623000571 |
|
Q3 2022
|
134 |
272,757 |
BLU.TO, KDNY, CHEMOCENTRYX INC, PEPPERLIME HEALTH ACQUSTN CO
|
13F-HR
|
11/14/2022 |
000142050622002182 |
|
Q2 2022
|
126 |
249,908 |
KDNY, BLU.TO, ADMA, ESPR
|
13F-HR
|
8/15/2022 |
000142050622001733 |
|
Q1 2022
|
118 |
298,809 |
PTGX calls, ESPR, BLU.TO, PTGX
|
13F-HR
|
5/16/2022 |
000142050622001092 |
|
Q4 2021
|
133 |
362,676 |
ESPR, PTGX, BLU.TO, BCYC
|
13F-HR
|
2/14/2022 |
000142050622000486 |
|
Q3 2021
|
124 |
381,251 |
GOED/WS, BLU.TO, CLDX, CTIC
|
RESTATEMENT
|
11/17/2021 |
000142050621001737 |
|
Q2 2021
|
135 |
431,131 |
GOED/WS, XTNT, PTGX, CRNX
|
13F-HR
|
8/13/2021 |
000142050621001151 |
|
Q1 2021
|
124 |
360,252 |
CRIS, VRCA, BIOR, CHARDAN HEALTHCR ACQSTN 2 CO
|
13F-HR
|
5/5/2021 |
000138713121005365 |
|
Q4 2020
|
94 |
267,866 |
OCUP, CRIS, OCUL, ISEE
|
RESTATEMENT
|
5/5/2021 |
000138713121005329 |